1 Comparison of the efficacy of available statistical methods for prediction of the hospitalizations number: proof of concept and validation based on the analysis of Polish National Health Fund data in the years 2009-2017.

2 Faculty Opinions Recommended Article: Efficacy of vedolizumab induction and maintenance therapy in patients with ulcerative colitis, regardless of prior exposure to tumor necrosis factor antagonists.

3 Is cytomegalovirus infection related to inflammatory bowel disease, especially steroid-resistant inflammatory bowel disease? A meta-analysis

4 Is cytomegalovirus infection related to inflammatory bowel disease, especially steroid-resistant inflammatory bowel disease? A meta-analysis

5 Therapeutic Drug Monitoring to Guide Clinical Decision Making in Inflammatory Bowel Disease Patients with Loss of Response to Anti-TNF: A Delphi Technique-Based Consensus.

6 A Matched Case-Control Analysis of Clinical Outcomes for Inflammatory Bowel Disease Patients with Rectal Cancer Treated with Pelvic Radiation Therapy.

7 Rate of, Risk Factors for, and Interventions to Reduce Hospital Readmission in Patients with Inflammatory Bowel Diseases.

8 Commentaries on "workshop report: Developing a pediatric inflammatory bowel diseases network and data platform in canada": International networking in pediatric gastroenterology research: Advancing science and medicine with collaborative efforts

9 Re: Erectile Dysfunction is Highly Prevalent in Men with Newly Diagnosed Inflammatory Bowel Disease

10 Pre-conception status, obstetric outcome and use of medications during pregnancy of systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) in Japan: multi-center retrospective descriptive study.

11 IMMUNIZATION STATUS OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE.

12 Endoscopic resection for non-polypoid dysplasia in inflammatory bowel disease: a systematic review protocol.

13 [Hodgkin's lymphoma associated with inflammatory bowel disease treated with thiopurines. A case report and review of the literature].

14 Association of Childhood-Onset Inflammatory Bowel Disease With Risk of Psychiatric Disorders and Suicide Attempt.

15 Diagnostic Challenges in the Early Onset of Inflammatory Bowel Disease: A Case Report.

16 Innovations in Oral Therapies for Inflammatory Bowel Disease.

17 The epidemiology of inflammatory bowel disease: East meets West.

18 Impaired Inactivation of Digestive Proteases in Lower Gut Due to Inhibition of Gut Bacteria by Food Additives Such as Saccharin and Sucralose as Main Cause of Inflammatory Bowel Disease: A Two-Decades-Long Hypothesis Warrants Testing

19 A Systematic Review of Case-Identification Algorithms Based on Italian Healthcare Administrative Databases for Three Relevant Diseases of the Digestive and Genitourinary System: Inflammatory Bowel Diseases, Celiac Disease, and Chronic Kidney Disease.

20 What Should We Expect from Future Therapies for Inflammatory Bowel Disease?

21 The clinical importance of 21-day combined parenteral and enteral nutrition in active inflammatory bowel disease patients

22 Diet in treatment of Inflammatory Bowel Diseases.

23 An In Situ Gelling System for the Local Treatment of Inflammatory Bowel Disease (IBD). The Loading of Maqui () Berry Extract as an Antioxidant and Anti-Inflammatory Agent.

24 Comparative genomics of a subset of Adherent/Invasive Escherichia coli strains isolated from individuals without inflammatory bowel disease.

25 Characteristics and pathogenic role of adherent-invasive Escherichia coli in inflammatory bowel disease: Potential impact on clinical outcomes.

26 The Inflammatory Bowel Disease Drug Azathioprine Induces Autophagy via mTORC1 and the Unfolded Protein Response Sensor PERK.

27 Pathobionts Associated with Inflammatory Bowel Disease.

28 CEACAM6 gene variants in inflammatory bowel disease.

29 W1225 ATG (but Not NOD2 or IRGM) Risk Alleles are Associated With Isolation of Adherent/Invasive E.Coli (AIEC) From Surgically Resected Human Inflammatory Bowel Disease (IBD) Tissues

30 Safety of Janus Kinase Inhibitors in Patients with Inflammatory Bowel Diseases or Other Immune-mediated Diseases: a Systematic Review and Meta-Analysis.

31 The Gut Microbiome in Inflammatory Bowel Diseases: Diagnostic and Therapeutic Implications.

32 When Family Don't Acknowledge: A Hermeneutic Study of the Experience of Kinship Stigma in Community-Dwelling People With Inflammatory Bowel Disease.

33 Regulation of Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells (NF-κβ) in Inflammatory Bowel Diseases

34 Small-molecule inhibitors directly target CARD9 and mimic its protective variant in inflammatory bowel disease.

35 Increased risks of dental caries and periodontal disease in Chinese patients with inflammatory bowel disease.

36 Physicians’ perspective on the clinical meaningfulness of inflammatory bowel disease trial results: an International Organization for the Study of Inflammatory Bowel Disease (IOIBD) survey

37 Semen Quality and Sperm DNA Integrity in Patients With Severe Active Inflammatory Bowel Disease and Effects of Tumour Necrosis Factor-alpha Inhibitors.

38 Sperm DNA Integrity is Unaffected by Thiopurine Treatment in Men With Inflammatory Bowel Disease.

39 Latent tuberculosis screening tests and active tuberculosis infection rates in Turkish inflammatory bowel disease patients under anti-tumor necrosis factor therapy.

40 Work Productivity Loss in Inflammatory Bowel Disease Patients in Turkey

41 Corona Virus Disease 2019 and Paediatric Inflammatory Bowel Diseases: Global Experience and Provisional Guidance (March 2020) from the Paediatric IBD Porto Group of European Society of Paediatric Gastroenterology, Hepatology, and Nutrition.

42 Telemedicine for Pediatric Inflammatory Bowel Disease in the Era of COVID-19.

43 Thromboprophylaxis for Hospitalized Patients with Inflammatory Bowel Disease—Are We There Yet?

44 A systematic review of disease-related stigmatization in patients living with inflammatory bowel disease

45 A systematic review of disease-related stigmatization in patients living with inflammatory bowel disease

46 Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target

47 lifestyle issues in children and adolescents with chronic inflammatory bowel diseases

48 frequency and significance of the novel single nucleotide missense polymorphism val109asp in the human gene encoding omentin in caucasian patients with type 2 diabetes mellitus or chronic inflammatory bowel diseases

49 cell therapy in experimental model of inflammatory bowel disease

50 functional characterization of inflammatory bowel diseaseâassociated gut dysbiosis in gnotobiotic micesummary

51 should we establish standards of care for management of elderly patients with inflammatory bowel disease?

52 markers of hypoxia correlate with histologic and endoscopic severity of colitis in inflammatory bowel disease

53 vedolizumab in patients with inflammatory bowel diseases of in real clinical practice

54 epidemiology in inflammatory bowel disease: unanswered questions - european perspective

55 the natural history of inflammatory bowel disease and primary sclerosing cholangitis after liver transplantation – a single-centre experience

56 nlrx1 modulates immunometabolic mechanisms controlling the host–gut microbiota interactions during inflammatory bowel disease

57 quality of life in patients with inflammatory bowel disease: importance of clinical, demographic and psychosocial factors

58 blockade of pld2 ameliorates intestinal mucosal inflammation of inflammatory bowel disease

59 the role of physical exercise in inflammatory bowel disease

60 intestinal epithelium in inflammatory bowel disease

61 implications of antioxidant systems in inflammatory bowel disease

62 Nutritional Interventions Using Functional Foods and Nutraceuticals to Improve Inflammatory Bowel Disease.

63 role of incretin axis in inflammatory bowel disease

64 are novel allergen or hydrolysed diets an effective means of reducing the gastro-intestinal signs in dogs with inflammatory bowel disease when compared to oral prednisolone?

65 qualidade de vida de pacientes portadores de doença inflamatória intestinal calidad de vida de pacientes portadores de enfermedad inflamatoria intestinal quality of life of patients with inflammatory bowel disease

66 combined treatment with hyaluronic acid and mesalamine protects rats from inflammatory bowel disease induced by intracolonic administration of trinitrobenzenesulfonic acid

67 defb1 gene 5' untranslated region (utr) polymorphisms in inflammatory bowel diseases

68 state of igg4-positive plasma cells in the colon mucosa of chronic inflammatory bowel disease

69 the immunological basis of inflammatory bowel disease

70 inflammatory bowel disease nurses in canada: an examination of canadian gastroenterology nurses and their role in inflammatory bowel disease care

71 the impact of glutathione s–transferase genotype and phenotype on the adverse drug reactions to azathioprine in patients with inflammatory bowel diseases

72 exercise in patients with inflammatory bowel diseases: current perspectives

73 evaluation of monocarboxylate transporter 4 in inflammatory bowel disease and its potential use as a diagnostic marker

74 benefits of zataria multiflora boiss in experimental model of mouse inflammatory bowel disease

75 the economic impact of inflammatory bowel disease in canada

76 induction of an antigen specific gut inflammatory reaction in mice and rats: a model for human inflammatory bowel disease

77 tumor necrosis factor receptor superfamily, member 1b haplotypes increase or decrease the risk of inflammatory bowel diseases in a new zealand caucasian population

78 mucosal complement deposition in inflammatory bowel disease

79 use of community resources before inflammatory bowel disease surgery is associated with postsurgical quality of life

80 early diagnosis and hematopoietic stem cell transplantation for il10r deficiency leading to very early-onset inflammatory bowel disease are essential in familial cases

81 disability in patients with inflammatory bowel disease: correlations with quality of life and patient’s characteristics

82 primary histoplasma capsulatum enterocolitis mimicking peptic and inflammatory bowel disease

83 worries and concerns among inflammatory bowel disease patients followed prospectively over one year

84 azathioprine in inflammatory bowel disease, a safe alternative?

85 comparison of fecal calprotectin methods for predicting relapse of pediatric inflammatory bowel disease

86 endoscopic diagnosis and differentiation of inflammatory bowel disease

87 the rationale for fk 506 in inflammatory bowel disease

88 how well does the internet answer patients’ questions about inflammatory bowel disease?

89 association between faecalibacterium prausnitzii reduction and inflammatory bowel disease: a meta-analysis and systematic review of the literature

90 th17 cell and epithelial cell crosstalk during inflammatory bowel disease and carcinogenesis

91 application of 5-aminosalicylic acid preparations in the treatment of inflammatory bowel diseases

92 drugs as causative agents and therapeutic agents in inflammatory bowel disease

93 ccr9 antagonism: potential in the treatment of inflammatory bowel disease

94 pancreatic involvement in pediatric inflammatory bowel disease

95 fecal calprotectin level as diagnostic marker for intestinal inflammation in inflammatory bowel disease patients

96 what made canada become a country with the highest incidence of inflammatory bowel disease: could sucralose be the culprit?

97 idiopathic portal hypertension regarding thiopurine treatment in patients with inflammatory bowel disease

98 osteomyelitis and osteonecrosis in inflammatory bowel disease

99 serrated adenoma prevalence in inflammatory bowel disease surveillance colonoscopy, and characteristics revealed by chromoendoscopy and virtual chromoendoscopy

100 controversies regarding the role of dairy products in inflammatory bowel disease

101 development and validation of an administrative case definition for inflammatory bowel diseases

Keyword Connections

Journals

Research Groups

Bibliographies